It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The pandemic burden caused by the SARS-CoV-2 coronavirus constitutes a global public health emergency. Increasing understanding about predisposing factors to infection and severity is now a priority. Genetic, metabolic, and environmental factors can play a crucial role in the course and clinical outcome of COVID-19. We aimed to investigate the putative relationship between genetic factors associated to obesity, metabolism and lifestyle, and the presence and severity of SARS-CoV-2 infection. A total of 249 volunteers (178 women and 71 men, with mean and ± SD age of 49 ± 11 years) characterized for dietary, lifestyle habits and anthropometry, were studied for presence and severity of COVID-19 infection, and genotyped for 26 genetic variants related to obesity, lipid profile, inflammation, and biorhythm patterns. A statistically significant association was found concerning a protective effect of APOE rs7412 against SARS-CoV-2 infection (p = 0.039; OR 0.216; CI 0.084, 0.557) after correction for multiple comparisons. This protective effect was also ascribed to the APOɛ2 allele (p = 0.001; OR 0.207; CI 0.0796, 0.538). The genetic variant rs7412 resulting in ApoE2, genetic determinant of lipid and lipoprotein levels, could play a significant role protecting against SARS-CoV-2 infection.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details



1 IMDEA-Food Institute, CEI UAM+CSIC, Madrid, Spain (GRID:grid.482878.9) (ISNI:0000 0004 0500 5302)
2 IMDEA-Food Institute, CEI UAM+CSIC, Madrid, Spain (GRID:grid.482878.9) (ISNI:0000 0004 0500 5302); Navarra Institute for Health Research (IdiSNA), Center for Nutrition Research (CIN), Pamplona, Spain (GRID:grid.508840.1) (ISNI:0000 0004 7662 6114); Institute of Health Carlos III, Center of Biomedical Research in Physiopathology of Obesity and Nutrition (CIBEROBN), Madrid, Spain (GRID:grid.413448.e) (ISNI:0000 0000 9314 1427)
3 IMDEA-Food Institute, CEI UAM+CSIC, Madrid, Spain (GRID:grid.482878.9) (ISNI:0000 0004 0500 5302); CEI UAM+CSIC, Institute of Food Science Research (CIAL), Madrid, Spain (GRID:grid.473520.7) (ISNI:0000 0004 0580 7575)